Persistent Parity-Induced Changes in Growth Factors, TGF-β3, and Differentiation in the Rodent Mammary Gland

MacMahon, 1970, Age at first birth and breast cancer risk., Bull World Health Organ, 43, 209

Rosner, 1994, Reproductive risk factors in a prospective study of breast cancer: the nurses’ health study., Am J Epidemiol, 139, 819, 10.1093/oxfordjournals.aje.a117079

Bain, 1981, Early age at first birth and decreased risk of breast cancer., Am J Epidemiol, 114, 705, 10.1093/oxfordjournals.aje.a113241

Layde, 1989, The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group., J Clin Epidemiol, 42, 963, 10.1016/0895-4356(89)90161-3

Paffenbarger, 1980, Characteristics that predict risk of breast cancer before and after the menopause., Am J Epidemiol, 112, 258, 10.1093/oxfordjournals.aje.a112992

Pathak, 1992, Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries., Am J Epidemiol, 135, 153, 10.1093/oxfordjournals.aje.a116268

Kvale, 1987, A prospective study of reproductive factors and breast cancer. I. Parity., Am J Epidemiol, 126, 831, 10.1093/oxfordjournals.aje.a114720

Vatten, 1992, Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women., Eur J Cancer, 28A, 1148, 10.1016/0959-8049(92)90476-I

Russo, 1978, Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylben(a)anthracene., J Natl Cancer Inst, 61, 1439

Russo, 1982, Differentiation of the mammary gland and susceptibility to carcinogenesis., Breast Cancer Res Treat, 2, 5, 10.1007/BF01805718

Thordarson, 1995, Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?, Carcinogenesis, 16, 2847, 10.1093/carcin/16.11.2847

Swanson, 1995, Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts., Cancer Lett, 90, 171, 10.1016/0304-3835(95)03712-6

Thordarson, 2001, Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones., Carcinogenesis, 22, 1027, 10.1093/carcin/22.7.1027

Guzman, 1999, Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy., Proc Natl Acad Sci USA, 96, 2520, 10.1073/pnas.96.5.2520

Nandi, 1995, Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis., Proc Natl Acad Sci USA, 92, 3650, 10.1073/pnas.92.9.3650

Russo, 1977, Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]anthracene., J Natl Cancer Inst, 59, 435, 10.1093/jnci/59.2.435

Moon, 1969, Relationship between previous reproductive history and chemically induced mammary cancer in rats., Int J Cancer, 4, 312, 10.1002/ijc.2910040308

Moon, 1981, Influence of pregnancy and lactation on experimental mammary carcinogenesis., Hormones and breast cancer., 353

Huggins, 1959, Critical significance of breast structure in the induction of mammary cancer in the rat., Proc Natl Acad Sci USA, 45, 1294, 10.1073/pnas.45.8.1294

Huggins, 1959, Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors., J Exp Med, 109, 25, 10.1084/jem.109.1.25

Huggins, 1961, Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression., Nature, 189, 204, 10.1038/189204a0

Dao, 1960, Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect ofpregnancy and lactation on tumor induction., J Natl Cancer Inst, 25, 991

Sivaraman, 1998, Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats., Carcinogenesis, 19, 1573, 10.1093/carcin/19.9.1573

Yang, 1999, Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats., Carcinogenesis, 20, 623, 10.1093/carcin/20.4.623

Medina, 1999, Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands., J Natl Cancer Inst, 91, 967, 10.1093/jnci/91.11.967

Daniel, 1987, Postnatal development of the rodent mammary gland., The mammary gland: development, regulation, and function., 3, 10.1007/978-1-4899-5043-7_1

Russo, 1990, Comparative study of human and rat mammary tumorigenesis., Lab Invest, 62, 244

Russo, 1992, Influence of age and parity on the development of the human breast., Breast Cancer Res Treat, 23, 211, 10.1007/BF01833517

Russo, 1993, Development pattern of human breast and susceptibility to carcinogenesis., Eur J Cancer Prevention, 2, 85, 10.1097/00008469-199311000-00013

Sinha, 1988, Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy., Br J Cancer, 57, 390, 10.1038/bjc.1988.88

Chodosh, 1999, Mammary gland development, reproductive history, and breast cancer risk., Cancer Res, 59, 1765

Ginger, 2001, Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland., Mol Endocrinol, 15, 1993, 10.1210/mend.15.11.0724

Gao, 2000, Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids., J Cell Physiol, 182, 297, 10.1002/(SICI)1097-4652(200002)182:2<297::AID-JCP19>3.0.CO;2-Z

Schroeder, 1998, Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland., Cell Growth Differ, 9, 451

Cooper, 1998, Differential expression of Id genes in multipotent myeloid progenitor cells: Id-1 is induced by early- and late-acting cytokines while Id-2 is selectively induced by cytokines that drive terminal granulocytic differentiation., J Cell Biochem, 71, 277, 10.1002/(SICI)1097-4644(19981101)71:2<277::AID-JCB12>3.0.CO;2-I

French, 1996, Modulation of clusterin gene expression in the rat mammary gland during pregnancy, lactation, and involution., Biol Reprod, 55, 1213, 10.1095/biolreprod55.6.1213

Jin, 1999, Transforming growth factor β regulates clusterin gene expression via modulation of transcription factor c-Fos., Eur J Biochem, 263, 534, 10.1046/j.1432-1327.1999.00533.x

Strange, 1992, Apoptotic cell death and tissue remodeling during mouse mammary gland involution., Development, 115, 49, 10.1242/dev.115.1.49

Shi, 2001, Hoxa-9 represses transforming growth factor-β-induced osteopontin gene transcription., J Biol Chem, 276, 850, 10.1074/jbc.M005955200

Nguyen, 2000, Transforming growth factor β3 induces cell death during the first stage of mammary gland involution., Development, 127, 3107, 10.1242/dev.127.14.3107

Kjeldsen, 1993, Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase., J Biol Chem, 268, 10425, 10.1016/S0021-9258(18)82217-7

Patarca, 1993, Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene., Crit Rev Immunol, 13, 225

Schumann, 1990, Structure and function of lipopolysaccharide binding protein., Science, 249, 1429, 10.1126/science.2402637

Denhardt, 1993, Osteopontin: a protein with diverse functions., FASEB J, 7, 1475, 10.1096/fasebj.7.15.8262332

Tatarczuch, 2000, Leucocyte phenotypes in involuting and fully involuted mammary glandular tissues and secretions of sheep., J Anat, 196, 313, 10.1046/j.1469-7580.2000.19630313.x

Dong, 1997, Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma., Cell, 88, 801, 10.1016/S0092-8674(00)81926-1

Ashkar, 2000, Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity., Science, 287, 860, 10.1126/science.287.5454.860

Harris, 1992, Breast cancer (2)., New Engl J Med, 327, 390, 10.1056/NEJM199208063270606

Panico, 1996, Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues., Int J Cancer, 65, 51, 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0

Normanno, 1995, Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas., Breast Cancer Res Treat, 35, 293, 10.1007/BF00665981

LeJeune, 1993, Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer., Cancer Res, 53, 3597

Niemeyer, 1999, Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice., Int J Cancer, 81, 588, 10.1002/(SICI)1097-0215(19990517)81:4<588::AID-IJC14>3.0.CO;2-I

Normanno, 1994, Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells., Proc Natl Acad Sci USA, 91, 2790, 10.1073/pnas.91.7.2790

Ma, 1999, Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line., Oncogene, 18, 6513, 10.1038/sj.onc.1203042

De Luca, 1999, EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells., Int J Cancer, 80, 589, 10.1002/(SICI)1097-0215(19990209)80:4<589::AID-IJC17>3.0.CO;2-D

Luetteke, 1999, Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development., Development, 126, 2739, 10.1242/dev.126.12.2739

Fang, 1992, Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer., J Biol Chem, 267, 25889, 10.1016/S0021-9258(18)35692-8

Kurtz, 1998, Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin., Biochem Soc Symp, 63, 51

Chauhan, 1993, Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice., Proc Natl Acad Sci USA, 90, 679, 10.1073/pnas.90.2.679

Zhang, 1997, Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant., J Biol Chem, 272, 16733, 10.1074/jbc.272.27.16733

Peyrat, 1992, Type 1 IGF receptor in human breast diseases., Breast Cancer Res Treat, 22, 59, 10.1007/BF01833334

Pezzino, 1996, Insulin-like growth factor-I (IGF-I) receptors in breast cancer., Ann NY Acad Sci, 784, 189, 10.1111/j.1749-6632.1996.tb16236.x

Pollak, 1998, Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention., Breast Cancer Res Treat, 47, 209, 10.1023/A:1005950916707

Rocha, 1997, Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival., Clin Cancer Res, 3, 103

Hankinson, 1998, Circulating concentrations of insulin-like growth factor-I and risk of breast cancer., Lancet, 351, 1393, 10.1016/S0140-6736(97)10384-1

Russo, 1987, Biological and molecular bases of mammary carcinogenesis., Lab Invest, 57, 112

Russo, 1999, Cellular basis of breast cancer susceptibility., Oncol Res, 11, 169

Sivaraman, 2001, p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis., Proc Natl Acad Sci USA, 98, 12379, 10.1073/pnas.221459098

Daniel, 1989, TGF-β1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization., Dev Biol, 135, 20, 10.1016/0012-1606(89)90154-1

Pierce Jr, 1995, Mammary tumor suppression by transforming growth factor β1 transgene expression., Proc Natl Acad Sci USA, 92, 4254, 10.1073/pnas.92.10.4254

Gorska, 1998, Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice., Cell Growth Differ, 9, 229

Bottinger, 1997, Transgenic mice overexpressing a dominant-negative type II tranforming growth factor receptor β receptor show enhanced tumorigenesis in the mammary gland and lung in reponse to the carcinogene 7,12-dimethylbenz-[a]-anthracene., Cancer Res, 57, 5564

Damiens, 1999, Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells., J Cell Biochem, 74, 486, 10.1002/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.0.CO;2-6

Hurley, 1994, In vitro inhibition of mammary cell growth by lactoferrin: a comparative study., Life Sci, 55, 1955, 10.1016/0024-3205(94)00528-1

Bezault, 1994, Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice., Cancer Res, 54, 2310

Damiens, 1998, Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells., Biochim Biophys Acta, 1402, 277, 10.1016/S0167-4889(98)00013-5

Shau, 1992, Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin., J Leukoc Biol, 51, 343, 10.1002/jlb.51.4.343

Marquis, 1995, The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues., Nat Genet, 11, 17, 10.1038/ng0995-17

Lockhart, 1996, Expression monitoring by hybridization to high-density oligonucleotide arrays., Nat Biotechnol, 14, 1675, 10.1038/nbt1296-1675